#USA #San Diego #Class Action #Robbins LLP #LifeMD

Robbins LLP's Class Action Against LifeMD, Inc.

LifeMD, Inc. (NASDAQ: LFMD) has come under fire as Robbins LLP pursues a class action lawsuit on behalf of shareholders who acquired its securities between May 7, 2025, and August 5, 2025. The lawsuit is essential for any investors who believe they suffered substantial losses during this time due to alleged misleading representations made by the company.

Allegations Against LifeMD

According to claims detailed in the filed complaint, LifeMD's leadership allegedly failed to disclose critical information that misrepresented the company’s actual business prospects and competitive standing. Specifically, it is alleged that:

1. LifeMD's management materially inflated the company's competitive position in the healthcare market.
2. The company recklessly raised its guidance for 2025 without adequately factoring in rising customer acquisition costs specifically related to its RexMD business segment, which includes medications for weight management.
3. As a result of these flawed statements, the disclosures surrounding LifeMD's operations and growth potential were deemed materially false, misleading, or lacking a reasonable foundation.

On August 5, 2025, LifeMD released its second-quarter earnings report, where it acknowledged "temporary challenges" faced within its RexMD segment. The company revised its guidance for revenue and adjusted EBITDA for the entire year of 2025 in light of these challenges. This announcement had an immediate adverse effect on the company's stock price, which plummeted by over 44% to close at $6.53 on August 6, 2025.

Your Options as an Investor

If you have incurred significant financial losses from your investment in LifeMD, you may be eligible to join the active class action lawsuit. Shareholders wishing to be considered as lead plaintiffs must file their papers with the court by October 27, 2025. This role involves representing the interests of all class members in guiding the ongoing litigation.

Moreover, it’s important to note that participating in this class action does not obligate you to pursue further legal action or financial recovery, as individuals may choose to remain as class members without active participation.

Robbins LLP operates on a contingency fee basis, meaning you are not responsible for any legal fees unless the case is won. This makes it accessible for many investors who are wary of upfront costs associated with legal action.

Robbins LLP: Your Advocates in Shareholder Rights

Since its inception in 2002, Robbins LLP has been a stalwart ally for shareholders, advocating for accountability and recovery of losses. The firm is dedicated to improving corporate governance and ensuring that company executives are held accountable for any wrongdoing that impacts investors.

To receive timely updates on the LifeMD class action lawsuit, or to stay informed about corporate governance issues that may affect your investments, consider signing up for Robbins LLP's Stock Watch service. By doing so, you'll gain access to free alerts and critical information regarding any settlements or lawsuits involving corporate misconduct.

Contact Information

If you believe you qualify for the class action or have more questions, you can reach out directly to Aaron Dumas Jr. at Robbins LLP. Contact information is as follows:

• - Email: [email protected]
• - Phone: (800) 350-6003
• - Address: 5060 Shoreham Pl., Suite 300, San Diego, CA 92122

Staying informed and taking action on these matters ensures that you safeguard your rights as an investor in the ever-evolving landscape of the financial markets.